204 related articles for article (PubMed ID: 31783318)
1. Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs.
Cramer JA; Yan T; Tieu R; Knoth RL; Fincher C; Malhotra M; Choi J
Epilepsy Behav; 2020 Jan; 102():106634. PubMed ID: 31783318
[TBL] [Abstract][Full Text] [Related]
2. Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States.
Fishman J; Martin M; Labiner DM; Lew CR; Johnson BH
Epilepsy Behav; 2019 Oct; 99():106331. PubMed ID: 31399339
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
Shcherbakova N; Rascati K; Brown C; Lawson K; Novak S; Richards KM; Yoder L
CNS Drugs; 2014 Nov; 28(11):1047-58. PubMed ID: 25086640
[TBL] [Abstract][Full Text] [Related]
4. Healthcare utilization and costs in children with stable and uncontrolled epilepsy.
Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2014 Mar; 32():135-41. PubMed ID: 24561658
[TBL] [Abstract][Full Text] [Related]
5. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.
Chen Z; Brodie MJ; Liew D; Kwan P
JAMA Neurol; 2018 Mar; 75(3):279-286. PubMed ID: 29279892
[TBL] [Abstract][Full Text] [Related]
7. Real-world impact of antiepileptic drug combinations with versus without perampanel on healthcare resource utilization in patients with epilepsy in the United States.
Laliberté F; Duh MS; Barghout V; Germain G; Frech F; Plauschinat C; Lejeune D; Malhotra M; Faught E
Epilepsy Behav; 2021 May; 118():107927. PubMed ID: 33812233
[TBL] [Abstract][Full Text] [Related]
8. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
[TBL] [Abstract][Full Text] [Related]
9. Newer antiepileptic drug use and other factors decreasing hospital encounters.
Faught E; Helmers SL; Begley CE; Thurman DJ; Dilley C; Clark C; Fritz P
Epilepsy Behav; 2015 Apr; 45():169-75. PubMed ID: 25819943
[TBL] [Abstract][Full Text] [Related]
10. Health-care costs and utilization related to long- or short-acting antiepileptic monotherapy use.
Cramer JA; Wang ZJ; Chang E; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2015 Mar; 44():40-6. PubMed ID: 25635369
[TBL] [Abstract][Full Text] [Related]
11. Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalization.
Manjunath R; Paradis PE; Parisé H; Lafeuille MH; Bowers B; Duh MS; Lefebvre P; Faught E
Neurology; 2012 Oct; 79(18):1908-16. PubMed ID: 23077014
[TBL] [Abstract][Full Text] [Related]
12. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
[TBL] [Abstract][Full Text] [Related]
13. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
Groth A; Wilke T; Borghs S; Gille P; Joeres L
Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
[No Abstract] [Full Text] [Related]
14. Rapid versus slow withdrawal of antiepileptic drugs.
Ranganathan LN; Ramaratnam S
Cochrane Database Syst Rev; 2006 Apr; (2):CD005003. PubMed ID: 16625621
[TBL] [Abstract][Full Text] [Related]
15. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Strozzi I; Nolan SJ; Sperling MR; Wingerchuk DM; Sirven J
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD001902. PubMed ID: 25922863
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
Hansen RN; Nguyen HP; Sullivan SD
Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
[TBL] [Abstract][Full Text] [Related]
17. Antiepileptic Drug Treatment in Community-Dwelling Older Patients with Epilepsy: A Retrospective Observational Study of Old- Versus New-Generation Antiepileptic Drugs.
Theitler J; Brik A; Shaniv D; Berkovitch M; Gandelman-Marton R
Drugs Aging; 2017 Jun; 34(6):479-487. PubMed ID: 28478592
[TBL] [Abstract][Full Text] [Related]
18. Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: A US database analysis.
Faught E; Helmers S; Thurman D; Kim H; Kalilani L
Epilepsy Behav; 2018 Aug; 85():37-44. PubMed ID: 29906700
[TBL] [Abstract][Full Text] [Related]
19. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
Sirven JI; Sperling M; Wingerchuk DM
Cochrane Database Syst Rev; 2001; (3):CD001902. PubMed ID: 11687000
[TBL] [Abstract][Full Text] [Related]
20. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
